Next week's exciting NASH FDA decision... $MDGL

$Madrigal Pharmaceuticals (MDGL.US)$ Are we days away from the 1st approved NASH/MASH therapy? 🤞
• After decades of trial and error in the field!

Resmetirom $MDGL for treating NASH/MASH 🧑‍🔬
• PDUFA date 3/14! 🗓️
• Impressive data
⇒ Ph3 MAESTRO-NASH trial
⇒ Met both key NASH endpoints - Fibrosis & NASH 📸 👇
⇒ Granted breakthrough therapy designation & priority review
⇒ Once daily, oral 💊
⇒ THR-β agonist
⇒ MDGL has run up into PDUFA... 📸 👇